论文信息 - AZD6244 enhances the anti-tumor activity of sorafenib in ectopic and orthotopic models of human hepatocellular carcinoma (HCC). - 字舞流文

AZD6244 enhances the anti-tumor activity of sorafenib in ectopic and orthotopic models of human hepatocellular carcinoma (HCC).

H. Huynh | K. Soo | H. Koong | C. Thng | H. Ong | A. Chung | P. Chow | B. Goh | Paul D. Smith | S. Choo | D. Poon | H. Toh | V. C. Ngo